These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32308534)

  • 21. Origins and Evolutionary Dynamics of H3N2 Canine Influenza Virus.
    Zhu H; Hughes J; Murcia PR
    J Virol; 2015 May; 89(10):5406-18. PubMed ID: 25740996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What We Have Learned from the Influenza A pH1N1 2009/10 Pandemic: High Clinical Impact of Human Metapneumovirus and Respiratory Syncytial Virus in Hospitalized Pediatric Patients.
    Vogel M; Grund S; Pandey S; Mayatepek E; Schroten H; Tenenbaum T; Adams O
    Jpn J Infect Dis; 2016; 69(1):6-11. PubMed ID: 25971322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seasonal influenza vaccination is the strongest correlate of cross-reactive antibody responses in migratory bird handlers.
    Oshansky CM; Wong SS; Jeevan T; Smallwood HS; Webby RJ; Shafir SC; Thomas PG
    mBio; 2014 Dec; 5(6):e02107. PubMed ID: 25491354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent developments in avian influenza research: epidemiology and immunoprophylaxis.
    Tollis M; Di Trani L
    Vet J; 2002 Nov; 164(3):202-15. PubMed ID: 12505393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent zoonoses caused by influenza A viruses.
    Alexander DJ; Brown IH
    Rev Sci Tech; 2000 Apr; 19(1):197-225. PubMed ID: 11189716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Verdinexor Targeting of CRM1 is a Promising Therapeutic Approach against RSV and Influenza Viruses.
    Pickens JA; Tripp RA
    Viruses; 2018 Jan; 10(1):. PubMed ID: 29361733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children.
    Iwane MK; Edwards KM; Szilagyi PG; Walker FJ; Griffin MR; Weinberg GA; Coulen C; Poehling KA; Shone LP; Balter S; Hall CB; Erdman DD; Wooten K; Schwartz B;
    Pediatrics; 2004 Jun; 113(6):1758-64. PubMed ID: 15173503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-Term Shedding of Influenza Virus, Parainfluenza Virus, Respiratory Syncytial Virus and Nosocomial Epidemiology in Patients with Hematological Disorders.
    Lehners N; Tabatabai J; Prifert C; Wedde M; Puthenparambil J; Weissbrich B; Biere B; Schweiger B; Egerer G; Schnitzler P
    PLoS One; 2016; 11(2):e0148258. PubMed ID: 26866481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses.
    Yoon JJ; Toots M; Lee S; Lee ME; Ludeke B; Luczo JM; Ganti K; Cox RM; Sticher ZM; Edpuganti V; Mitchell DG; Lockwood MA; Kolykhalov AA; Greninger AL; Moore ML; Painter GR; Lowen AC; Tompkins SM; Fearns R; Natchus MG; Plemper RK
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of Influenza A and B Viruses and Respiratory Syncytial Virus by Use of Clinical Laboratory Improvement Amendments of 1988 (CLIA)-Waived Point-of-Care Assays: a Paradigm Shift to Molecular Tests.
    Azar MM; Landry ML
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29695519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of acute respiratory infections due to influenza virus A, B and RSV during an influenza epidemic 2018.
    Topoulos S; Giesa C; Gatermann S; Fussen R; Lemmen S; Ewig S
    Infection; 2019 Jun; 47(3):425-433. PubMed ID: 30649684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Simultaneous detection of respiratory viruses and influenza A virus subtypes using multiplex PCR].
    Ciçek C; Bayram N; Anıl M; Gülen F; Pullukçu H; Saz EU; Telli C; Cok G
    Mikrobiyol Bul; 2014 Oct; 48(4):652-60. PubMed ID: 25492660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods.
    Nguyen HT; Fry AM; Gubareva LV
    Antivir Ther; 2012; 17(1 Pt B):159-73. PubMed ID: 22311680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wet markets--a continuing source of severe acute respiratory syndrome and influenza?
    Webster RG
    Lancet; 2004 Jan; 363(9404):234-6. PubMed ID: 14738798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence and Clinical Course of Respiratory Viral Coinfections in Children Aged 0-59 Months.
    Nitsch-Osuch A; Kuchar E; Topczewska-Cabanek A; Wardyn K; Życińska K; Brydak L
    Adv Exp Med Biol; 2016; 905():17-23. PubMed ID: 26801151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. INFECTIONS IN PREGNANCY WITH COVID-19 AND OTHER RESPIRATORY RNA VIRUS DISEASES ARE RARELY, IF EVER, TRANSMITTED TO THE FETUS: EXPERIENCES WITH CORONAVIRUSES, HPIV, hMPV RSV, AND INFLUENZA.
    Schwartz DA; Dhaliwal A
    Arch Pathol Lab Med; 2020 Apr; ():. PubMed ID: 32338533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Avian Influenza A Virus Pandemic Preparedness and Vaccine Development.
    de Vries RD; Herfst S; Richard M
    Vaccines (Basel); 2018 Jul; 6(3):. PubMed ID: 30044370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of human metapneumovirus in childhood: comparison with respiratory syncytial virus and influenza viruses.
    Bosis S; Esposito S; Niesters HG; Crovari P; Osterhaus AD; Principi N
    J Med Virol; 2005 Jan; 75(1):101-4. PubMed ID: 15543589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modelling estimates of the burden of Respiratory Syncytial virus infection in adults and the elderly in the United Kingdom.
    Fleming DM; Taylor RJ; Lustig RL; Schuck-Paim C; Haguinet F; Webb DJ; Logie J; Matias G; Taylor S
    BMC Infect Dis; 2015 Oct; 15():443. PubMed ID: 26497750
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.